Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastoma
about
MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsSystems biology of cisplatin resistance: past, present and futureLet-7 Sensitizes KRAS Mutant Tumor Cells to ChemotherapyMicroRNAs: novel players in cancer diagnosis and therapies.MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.Circulating microRNAs as potential biomarkers for endometriosis.MicroRNA-610 suppresses the proliferation of human glioblastoma cells by repressing CCND2 and AKT3.Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.MicroRNAs in brain development and function: a matter of flexibility and stability.Blockage of epithelial to mesenchymal transition and upregulation of let 7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell.Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression.MicroRNAs and cell cycle of malignant glioma.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line.Non-equivalent Roles of AGO1 and AGO2 in mRNA Turnover and Translation of Cyclin D1 mRNA.MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, KRAS to paclitaxel treatment.Nitroxoline induces apoptosis and slows glioma growth in vivo.miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.MicroRNA in Glioblastoma: An Overview.MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.Role of family microRNA in breast cancerThe Network of Non-coding RNAs in Cancer Drug Resistance
P2860
Q26747273-A227C3DC-A144-4065-8CEA-F9F6BF8A22C5Q26863585-66B48361-9048-403D-8A05-222B2CC479B2Q28547017-5F3FE3F2-4AE0-4258-8477-AC4B2A629441Q33914573-A485A80E-A80B-450D-8FD9-31FFC2C36E85Q35293359-6745FC5F-956B-47B8-B8D5-4D60DE4022F5Q35562931-56791BAF-1D24-4E60-8186-7449ACC9BDDAQ36624011-562AB31D-119D-40C5-855D-2DAD3CA95248Q37327471-479B45E7-C4EF-4C05-B8DD-F0ECBAE24264Q37564200-23AAAFBD-C3C0-48B9-84AF-2F186A9173A0Q37585990-15CBB47C-43A7-4574-B115-053CA6F79016Q37736667-92B8B61B-43F5-4ABA-B506-2C0D058B3102Q38452459-0742465F-5B93-4823-A1F5-A59FAA75221AQ38497875-A99FD35E-FC3B-433C-A2E8-35350D963187Q38546133-ECAC731A-6C6B-42E8-8162-DF220C0828B6Q38695476-AE0D7895-4AD1-402E-9D53-E773462C12B7Q38796473-2A1950A6-3600-4FA5-A769-F66A33F21345Q38818609-8B5E6A78-8931-41DB-9BA8-BA2A520D9C15Q38970495-390EAE1E-F337-40DC-AECF-0FE6C8E5D66CQ39020586-3BE5CF40-F563-43D6-8659-A6F4DF0CE254Q47142132-6DBA1E30-1594-459A-B3A5-B956C584FFFCQ48595565-CB10640A-BF3E-40FC-BF30-A0C5DB41E0BDQ57119043-7EDD1BEA-F701-4946-882C-9B2A78039383Q58694197-D6C23FBB-4C3D-4504-B6E8-EB8C66759996
P2860
Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastoma
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Let-7b expression determines r ...... n of cyclin D1 in glioblastoma
@en
Let-7b expression determines r ...... of cyclin D1 in glioblastoma.
@nl
type
label
Let-7b expression determines r ...... n of cyclin D1 in glioblastoma
@en
Let-7b expression determines r ...... of cyclin D1 in glioblastoma.
@nl
prefLabel
Let-7b expression determines r ...... n of cyclin D1 in glioblastoma
@en
Let-7b expression determines r ...... of cyclin D1 in glioblastoma.
@nl
P2093
P2860
P356
P1476
Let-7b expression determines r ...... n of cyclin D1 in glioblastoma
@en
P2093
Fenghua Chen
Jiasheng Fang
P2860
P2888
P356
10.1186/1756-9966-32-41
P577
2013-06-27T00:00:00Z
P5875
P6179
1028284873